Download App

Log in to access Online Inquiry
Company Overview More
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals dedicated to the discovery or licensing, development and commercialization of proprietary therapies to address a large number of unmet medical needs in the Chinese market, including oncology, autoimmunity and infectious diseases. The company has a range of patent candidates from the discovery phase to the later stages of the clinical program. It includes Niraparib (ZL-2306), ZL-2103, ZL-1101 and so on.
CEO: Ying Du
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 09688 ZAI LAB-SB > Detailed Quotes

09688 ZAI LAB-SB

26.750-1.250-4.46%
Market Close 05/25 16:08 CCT
High
27.450
Open
26.000
Turnover
16.73M
Low
26.000
Pre Close
28.000
Volume
621.91K
Market Cap
26.19B
P/E(TTM)
Loss
52wk High
142.000
Shares
979.09M
P/E(Static)
Loss
52wk Low
19.920
Float Cap
26.19B
Bid/Ask %
78.20%
Historical High
151.200
Shs Float
979.09M
Volume Ratio
1.24
Historical Low
19.920
Dividend TTM
--
Div Yield TTM
--
P/B
2.56
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.06%
Amplitude
5.18%
Avg Price
26.901
Lot Size
100
Float Cap
26.19B
Bid/Ask %
78.20%
Historical High
151.200
Shs Float
979.09M
Volume Ratio
1.24
Historical Low
19.920
Dividend TTM
--
P/B
2.56
Dividend LFY
--
Turnover Ratio
0.06%
Amplitude
5.18%
Avg Price
26.901
Lot Size
100
Price Forecast

No Data

News

Comment